- Filed
- Apr 30, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 123.89M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.12B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.14B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $225.75M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $225.58M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.6B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.63B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $927.03M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.06B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.34B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.49B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $525.54M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $1.03B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 121.71M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $6.93M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$30.28M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $68.29M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $158.68M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.94 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.94 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $38.65M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $83.8M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$114.99M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$99.68M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $65.3M |
| Revenue | Q1 2025 · Mar 31, 2024 | $168.49M |